Skip to main content
logo
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.29
-0.04 (-0.55%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Precision BioSciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
45.0734.2668.748.7325.1115.53
Revenue Growth
-11.87%-50.12%40.98%94.15%-78.28%375.72%
Gross Profit
45.0734.2668.748.7325.1115.53
Selling, General & Admin
-30.49-32.24-35.3-39.09-41.28-39.67
Research & Development
-53.69-54.17-59.56-53.38-46.12-115.24
Other Operating Expenses
-0.04----
Total Operating Expenses
-84.18-86.38-94.86-92.46-87.41-154.91
Operating Income
129.26120.64163.55141.19112.5270.43
Total Non-Operating Income (Expense)
-5.375.5433.331.21-10.68.77
Pretax Income
123.88126.18196.88142.4101.9279.21
Net Income
123.88126.18196.88142.4101.9279.21
Earnings From Discontinued Operations
-0.89----
Net Income to Common
-18.44-45.727.17142.4-111.64-30.6
Net Income Growth
---94.97%---
Shares Outstanding (Basic)
17137432
Shares Outstanding (Diluted)
17137432
Shares Change
111.05%86.32%79.20%31.11%49.77%12.79%
EPS (Basic)
-3.66-3.561.05-15.96-38.10-15.60
EPS (Diluted)
-3.67-3.561.04-15.96-38.10-15.60
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-58.77-65.93-58.7-86.07-49.07-15.91
Free Cash Flow Growth
------
Free Cash Flow Per Share
-3.53-5.14-8.53-22.41-16.75-8.13
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
286.77%352.09%238.08%289.76%448.26%234.08%
Profit Margin
274.85%368.25%286.60%292.24%406.02%241.68%
FCF Margin
-130.38%-192.41%-85.44%-176.64%-195.52%-13.77%
EBITDA
130.63122.11166.96148.01120.3279.42
EBITDA Margin
289.82%356.37%243.04%303.75%479.33%241.86%
EBIT
129.26120.64163.55141.19112.5270.43
EBIT Margin
286.77%352.09%238.08%289.76%448.26%234.08%
SEC Filings: 10-K · 10-Q